Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: E9ARB1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 96 | 98 | PF00675 | 0.435 |
CLV_PCSK_FUR_1 | 94 | 98 | PF00082 | 0.470 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.403 |
CLV_PCSK_KEX2_1 | 96 | 98 | PF00082 | 0.441 |
CLV_PCSK_PC1ET2_1 | 51 | 53 | PF00082 | 0.403 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 86 | 90 | PF00082 | 0.571 |
DOC_PP1_RVXF_1 | 55 | 62 | PF00149 | 0.507 |
DOC_PP4_FxxP_1 | 24 | 27 | PF00568 | 0.553 |
DOC_PP4_FxxP_1 | 61 | 64 | PF00568 | 0.438 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.501 |
DOC_WW_Pin1_4 | 105 | 110 | PF00397 | 0.508 |
DOC_WW_Pin1_4 | 12 | 17 | PF00397 | 0.525 |
DOC_WW_Pin1_4 | 124 | 129 | PF00397 | 0.425 |
DOC_WW_Pin1_4 | 19 | 24 | PF00397 | 0.550 |
DOC_WW_Pin1_4 | 32 | 37 | PF00397 | 0.561 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.612 |
LIG_CSL_BTD_1 | 106 | 109 | PF09270 | 0.514 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.481 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.405 |
LIG_FHA_1 | 87 | 93 | PF00498 | 0.357 |
LIG_LIR_Apic_2 | 22 | 27 | PF02991 | 0.556 |
LIG_LIR_Nem_3 | 15 | 21 | PF02991 | 0.551 |
LIG_PDZ_Class_1 | 124 | 129 | PF00595 | 0.392 |
LIG_SH2_PTP2 | 18 | 21 | PF00017 | 0.558 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.470 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.626 |
LIG_SH2_STAT5 | 46 | 49 | PF00017 | 0.541 |
LIG_SH3_3 | 103 | 109 | PF00018 | 0.578 |
MOD_CDK_SPK_2 | 105 | 110 | PF00069 | 0.508 |
MOD_CDK_SPK_2 | 12 | 17 | PF00069 | 0.545 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.537 |
MOD_CK2_1 | 39 | 45 | PF00069 | 0.548 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.593 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.620 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.573 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.442 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.580 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.539 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.444 |
MOD_PKA_1 | 96 | 102 | PF00069 | 0.437 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.613 |
MOD_PKB_1 | 94 | 102 | PF00069 | 0.443 |
MOD_Plk_1 | 44 | 50 | PF00069 | 0.480 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.369 |
MOD_Plk_4 | 9 | 15 | PF00069 | 0.483 |
MOD_ProDKin_1 | 105 | 111 | PF00069 | 0.509 |
MOD_ProDKin_1 | 12 | 18 | PF00069 | 0.531 |
MOD_ProDKin_1 | 19 | 25 | PF00069 | 0.552 |
MOD_ProDKin_1 | 32 | 38 | PF00069 | 0.560 |
TRG_ENDOCYTIC_2 | 18 | 21 | PF00928 | 0.662 |
TRG_ER_diArg_1 | 93 | 96 | PF00400 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P845 | Leptomonas seymouri | 63% | 96% |
A0A0S4J864 | Bodo saltans | 32% | 100% |
A0A1X0NSP0 | Trypanosomatidae | 53% | 100% |
A0A3R7MB48 | Trypanosoma rangeli | 50% | 100% |
A0A3S7WUQ8 | Leishmania donovani | 91% | 100% |
A4H994 | Leishmania braziliensis | 83% | 100% |
A4HXL5 | Leishmania infantum | 91% | 100% |
C9ZPA9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
Q4QE52 | Leishmania major | 89% | 99% |